Evaluation of Immune Response towards Hepatitis B Virus Vaccination among Vaccinated Students of Ardebil University of Medical Sciences in Iran

Authors
1 Department of Immunology and Microbiology, School of Medicine, Ardabil University of Medical Sciences, Ardabil, IR Iran
2 Young Researchers and Elite Club, Islamic Azad University, Tabriz Branch, Tabriz, IR Iran
3 Department of Infectious Disease and Tropical Medicine, Imam Khomeini Hospital, Ardabil University of Medical Science, Ardabil, IR Iran
4 Department of Biostatistics, Faculty of Health, Ardabil University of Medical Sciences, Ardabil, IR Iran
5 Department of Genetics, Islamic Azad University, Science and Research Branch, Tehran, IR Iran
6 Department of Hematology and Blood Banking, School of allied Medicine, Urmia University of medical sciences, Urmia, IR Iran
Abstract
Background: Hepatitis B infection is a major public health problem worldwide. Given that immune response towards the vaccine is not perfect, we aimed to evaluate circumstances of immune response in vaccinated students.
Materials and Methods: In this study, 219 medical students of Ardabil University of Medical Sciences were recruited, who had been administered vaccine series for the first time, and booster doses after one and six months completely. The serum samples were extracted from whole blood of the participants. The concentration of Hepatitis B surface antigen (HBsAg) and anti-HBs antibody (HBsAb) was measured using a commercial ELISA kit.
Results: It was observed that 201 cases (91.8%) out of 219 cases had positive anti-HBs antibody response, and 18 subjects (8.2%) were nonresponsive cases. Level of HBsAb was significantly different between males and females as well as alcoholics and non-alcoholics. None of the cases was identified as positive for HBsAg.
Conclusion: Considering the results of the present and previous studies in other countries, it can be claimed that the mass vaccination has been effective, especially in medical students.

Keywords


1.    Shepard CW, Simard EP, Finelli L, Fiore AE, Bell BP. Hepatitis B virus infection: epidemiology and vaccination. Epidemiol rev. 2006; 28(1): 112-25.
2.    Horvat RT. Diagnostic and clinical relevance of HBV mutations. Lab Med. 2011; 42(8): 488-96.
3.    Abdolsamadi H, Vaziri PB, Abdollahzadeh S, Kashani KM, Vahedi M. Immune response to Hepatitis B vaccine among dental students. Iran J Public Health. 2009; 38(2): 113-8.
4.    Miguel J, Coquette A, Bresson-Hadni S. [The other types of viral hepatitis]. La Revue du praticien. 1990; 40(18): 1656-9.
5.    Kaplowitz N. Drug-induced liver injury. Clin Infect Dis. 2004; 38(Suppl 2): S44-8.
6.    Koff RS. Vaccines and Hepatitis B. Clin Liver Dis. 1999; 3(2): 417-28.
7.    Zajac B, West D, McAleer W, Scolnick E. Overview of clinical studies with Hepatitis B vaccine made by recombinant DNA. J Infect. 1986; 13: 39-45.
8.    Villeneuve JP, Condreay LD, Willems B, Pomier‐Layrargues G, Fenyves D, Bilodeau M, et al. Lamivudine treatment for decompensated cirrhosis resulting from chronic Hepatitis B. Hepat. 2000; 31(1): 207-10.
9.    Foy MC, Thio CL, Hwang HS, Saulynas M, Hamilton JP, Fine DM, et al. False-negative Hepatitis B virus (HBV) surface antigen in a vaccinated dialysis patient with a high level of HBV DNA in the United States. Clin Vaccine Immunol. 2012; 19(5): 820-2.
10.  Ferreira CT, Silveira TRd. Viral hepatitis prevention by immunization. J Pediatr (Rio J). 2006; 82(3): s55-s66.
11.  Chakraborty B, Bashar T, Roy K, Noor R, Rahman MM. Persistence of anti-HBs antibody and immunological memory in healthy individuals vaccinated with Hepatitis B vaccine. Stamford J Microbiol. 2011; 1(1): 37-41.
12.  Mansour GF, Fallah M, Jafarshad R, Joukar F, Arami M, Ale-Esmaeil A, et al. The Immunologic Response to anti-hepatitis B vaccination among medical students of Guilan University of Medical Sciences, Guilan. Iran Hepat Mon. 2006; 6(2): 63-66.
13.  Taheri H, Hasanjani Roushan MR, Soleimani Amiri MJ, Pouralijan M,Bijani A. Efficacy of Hepatitis B vaccine in those who lost Hepatitis B surface antigen during follow-up. Hepat Mon. 2011; 11(2): 119-122.
14.  Zuckerman JN, Sabin C, Fiona MC, Williams A, Zuckerman AJ. Immune response to a new Hepatitis B vaccine in healthcare workers who had not responded to standard vaccine: randomised double blind dose-response study. BMJ. 1997; 314(7077): 329-33.
15.  Marocho L, Vildozola H, Valencia E, Romero G, Huaman A, Solano L, et al. [Comparative study on the protective effect of two immunization schemes using a Hepatitis B recombinant vaccine in vulnerable health science students]. Rev Gastroenterol Peru. 2004; 25(4): 313-319.
16.  Mozes E, McDevitt HO, Jaton J-C, Sela M. The nature of the antigenic determinant in a genetic control of the antibody response.  J Exp Med. 1969; 130(3): 493-504.
17.  Varla‐Laftnerioti M, Papanicolaou M, Spyropoulou M, Vallindra H, Tsiroyianni P, Tassopoulos N, et al. HLA‐associated non‐responsiveness to Hepatitis B vaccine. Tissue Antigens. 1990; 35(2): 60-3.
18.  Milich D, Chisari F. Genetic regulation of the immune response to Hepatitis B surface antigen (HBsAg). I. H-2 restriction of the murine humoral immune response to the a and d determinants of HBsAg. J Immunol. 1982; 129(1): 320-5.
19.  Milich DR, Leroux-Roels GG, Louie RE. Genetic regulation of the immune response to Hepatitis B surface antigen (HBsAg). J Exp Med. 1984; 159: 41-56.
20.  Vranckx R, Muylle L, Cole J, Moldenhaser R, Peetermans M. HBV vaccinations in medical and paramedical staff: the impact of age on immunization results. Vox Sang. 1986; 50(4): 220-2.
21.  Janbakhsh A, Mansouri F, Vaziri S, Sayad B, Afsharian M, Rahimi M, et al. Effect of selenium on immune response against Hepatitis B vaccine with accelerated method in insulin-dependent diabetes mellitus patients. Caspian J Int Med. 2013; 4(1): 603-6.
22.  Perera J, Perera B, Gamage S. Seroconversion after Hepatitis B vaccination in healthy young adults, and the effect of a booster dose. Ceylon Med J. 2014; 47(1): 6-8.
23.  Alavian SM, Mahboobi N, Mahboobi N. Anti-HBs antibody status and some of its associated factors in dental health care workers in Tehran University of Medical Sciences: Anti-HBs Ab and associated factors in dental society. Hepat Mon. 2011; 11(2): 99-102.
24.  Parker DC. T cell-dependent B cell activation. Annu Rev Immunol. 1993; 11(1): 331-60.
25.  Jee SH, Ohrr H, Sull JW, Samet JM. Cigarette smoking, alcohol drinking, Hepatitis B, and risk for hepatocellular carcinoma in Korea. J Natl Cancer Inst. 2004; 96(24): 1851-6.
26.  Chopra S, Tupper J, Ahn C, Bayog R, Koff R, editors. Hepatitis-B markers in an alcohol treatment unit. Gastroenterology; 1980: WB Saunders Co Independence Square West Curtis Center, Ste 300, Philadelphia, PA 19106-3399.
27.  Vargas V, Pedreira JD, Esteban R, Hernández JM, Guardia J, Bacardi R. Hepatitis B virus infection in alcoholic cirrhosis. Br Med J (Clin ResEd). 1981; 282(6277): 1705-6.
28.  Rosman AS, Basu P, Galvin K, Lieber CS. Efficacy of a high and accelerated dose of Hepatitis B vaccine in alcoholic patients: A randomized clinical trialfn1fn1.This research was supported by DHHS Grant AA-07275, the department of veterans affairs, the Kingsbridge Research Foundation, and SmithKline Beecham Pharmaceuticals. Am J Med. 1997; 103(3): 217-22.